ES438931A1 - Procedimiento para la preparacion de nuevos derivados de amino-3 hidroxi-2 fenoxi-1 propano. - Google Patents

Procedimiento para la preparacion de nuevos derivados de amino-3 hidroxi-2 fenoxi-1 propano.

Info

Publication number
ES438931A1
ES438931A1 ES438931A ES438931A ES438931A1 ES 438931 A1 ES438931 A1 ES 438931A1 ES 438931 A ES438931 A ES 438931A ES 438931 A ES438931 A ES 438931A ES 438931 A1 ES438931 A1 ES 438931A1
Authority
ES
Spain
Prior art keywords
overproduction
compositions
treatment
conditions associated
catecholamines
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
ES438931A
Other languages
English (en)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Clin Midy
Original Assignee
Clin Midy
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Clin Midy filed Critical Clin Midy
Publication of ES438931A1 publication Critical patent/ES438931A1/es
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D303/00—Compounds containing three-membered rings having one oxygen atom as the only ring hetero atom
    • C07D303/02—Compounds containing oxirane rings
    • C07D303/12—Compounds containing oxirane rings with hydrocarbon radicals, substituted by singly or doubly bound oxygen atoms
    • C07D303/18—Compounds containing oxirane rings with hydrocarbon radicals, substituted by singly or doubly bound oxygen atoms by etherified hydroxyl radicals
    • C07D303/20—Ethers with hydroxy compounds containing no oxirane rings
    • C07D303/22—Ethers with hydroxy compounds containing no oxirane rings with monohydroxy compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
ES438931A 1974-06-28 1975-06-27 Procedimiento para la preparacion de nuevos derivados de amino-3 hidroxi-2 fenoxi-1 propano. Expired ES438931A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB28925/74A GB1501632A (en) 1974-06-28 1974-06-28 Aromatic ketones having cardiovascular activity

Publications (1)

Publication Number Publication Date
ES438931A1 true ES438931A1 (es) 1977-05-16

Family

ID=10283421

Family Applications (1)

Application Number Title Priority Date Filing Date
ES438931A Expired ES438931A1 (es) 1974-06-28 1975-06-27 Procedimiento para la preparacion de nuevos derivados de amino-3 hidroxi-2 fenoxi-1 propano.

Country Status (17)

Country Link
US (2) US4252825A (es)
JP (2) JPS5826743B2 (es)
AR (1) AR205388A1 (es)
AT (1) AT343098B (es)
BE (1) BE830766A (es)
CA (1) CA1052820A (es)
CS (1) CS197248B2 (es)
DE (1) DE2528147A1 (es)
DK (1) DK143555C (es)
ES (1) ES438931A1 (es)
FR (1) FR2276032A1 (es)
GB (1) GB1501632A (es)
IE (1) IE41386B1 (es)
NL (1) NL7507703A (es)
SE (2) SE416546B (es)
YU (1) YU165775A (es)
ZA (1) ZA754141B (es)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1501632A (en) * 1974-06-28 1978-02-22 Cm Ind Aromatic ketones having cardiovascular activity
JPH0516363Y2 (es) * 1986-08-01 1993-04-28
RS20050106A (en) 2002-08-19 2007-11-15 Pfizer Products Inc., Combination therapy for hyperproliferative diseases
SG141430A1 (en) * 2003-05-30 2008-04-28 Ranbaxy Lab Ltd Substituted pyrrole derivatives and their use as hmg-co inhibitors
US20050037063A1 (en) * 2003-07-21 2005-02-17 Bolton Anthony E. Combined therapies
GT200600381A (es) 2005-08-25 2007-03-28 Compuestos organicos
US7741317B2 (en) 2005-10-21 2010-06-22 Bristol-Myers Squibb Company LXR modulators
BRPI0618379A2 (pt) * 2005-11-08 2011-08-30 Ranbaxy Lab Ltd processo para preparação do hemi-sal de cálcio do ácido (3r,5r) -7-[2-(4-fluorofenil)-5-isopropil-3-fenil-4-[(4-hidroxime tilfenilamino) carbonil]-pirrol-1-il] -3, 5-diidroxi heptanóico
US7888376B2 (en) 2005-11-23 2011-02-15 Bristol-Myers Squibb Company Heterocyclic CETP inhibitors
TW200744583A (en) * 2006-03-14 2007-12-16 Ranbaxy Lab Ltd Statin stabilizing dosage formulations
US20080153896A1 (en) * 2006-07-14 2008-06-26 Gyan Chand Yadav Polymorphic Forms of an HMG-CoA Reductase Inhibitor and Uses Thereof
ATE547394T1 (de) 2006-12-01 2012-03-15 Bristol Myers Squibb Co N-((3-benzyl)-2,2-(bis-phenyl)-propan-1- aminderivate als cetp-hemmer für die behandlung von atherosklerose und herz-kreislauf- erkrankungen
AU2014255381A1 (en) 2013-04-17 2015-10-08 Pfizer Inc. N-piperidin-3-ylbenzamide derivatives for treating cardiovascular diseases
WO2016055901A1 (en) 2014-10-08 2016-04-14 Pfizer Inc. Substituted amide compounds
JOP20210193A1 (ar) 2019-01-18 2023-01-30 Astrazeneca Ab مثبطات pcsk9 وطرق استخدامها

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL301580A (es) * 1962-12-11
DE1493454C3 (de) * 1963-08-26 1980-04-30 C.H. Boehringer Sohn, 6507 Ingelheim 1 -Aryloxy^-hydroxy-S-isopropylaminopropane und deren Salze sowie deren Herstellung und darauf basierende Arzneimittel
US3637852A (en) * 1963-08-26 1972-01-25 Boehringer Sohn Ingelheim 1-phenoxy-2-hydroxy-3-isopropylamino-propanes and salts thereof
GB1231783A (en) * 1967-05-16 1971-05-12 May & Baker Ltd Benzene derivatives
JPS512115B2 (es) * 1971-09-28 1976-01-23
JPS4911847A (es) * 1972-05-20 1974-02-01
GB1501632A (en) * 1974-06-28 1978-02-22 Cm Ind Aromatic ketones having cardiovascular activity

Also Published As

Publication number Publication date
DK143555B (da) 1981-09-07
US4252825A (en) 1981-02-24
FR2276032B1 (es) 1979-08-10
SE7507359L (sv) 1975-12-29
DK292475A (da) 1975-12-29
FR2276032A1 (fr) 1976-01-23
IE41386B1 (en) 1979-12-19
US4302601A (en) 1981-11-24
JPS5929574B2 (ja) 1984-07-21
JPS5123233A (en) 1976-02-24
SE417087B (sv) 1981-02-23
AU8256675A (en) 1977-01-06
AT343098B (de) 1978-05-10
JPS5826743B2 (ja) 1983-06-04
GB1501632A (en) 1978-02-22
SE416546B (sv) 1981-01-19
CS197248B2 (en) 1980-04-30
BE830766A (fr) 1975-12-29
SE7812646L (sv) 1978-12-08
AR205388A1 (es) 1976-04-30
JPS58140050A (ja) 1983-08-19
CA1052820A (en) 1979-04-17
IE41386L (en) 1975-12-28
DK143555C (da) 1982-02-01
ATA497275A (de) 1977-09-15
YU165775A (en) 1982-02-28
ZA754141B (en) 1976-06-30
NL7507703A (nl) 1975-12-30
DE2528147A1 (de) 1976-01-15

Similar Documents

Publication Publication Date Title
ES438931A1 (es) Procedimiento para la preparacion de nuevos derivados de amino-3 hidroxi-2 fenoxi-1 propano.
ES8307744A1 (es) Un metodo para la preparacion de nuevos derivados de sales de metales alcalinos de acidos 2-pirrolidon-4-carboxilicos.
ES425514A1 (es) Un procedimiento para la preparacion de nuevas 3-nitrocuma-rinas.
ES433860A1 (es) Procedimiento de preparacion de derivados del acido ciclo- pentano-carboxilico.
ES400452A1 (es) Procedimiento para la obtencion de un medio para regular el crecimiento de las plantas a base de acidos 2-halogenoe- tano sulfinicos.
IE780497L (en) Broparestrol based therapeutic compositions
IL35249A0 (en) The use of 2-chloroethane-phosphonic and thiono-phosphonic acid amino compounds as agents for the regulation of plant growth
ES435559A1 (es) Un procedimiento para la preparacion de nuevos derivados deacidos xantonacarboxilicos sustituidos.
ES354823A1 (es) Procedimiento para la preparacion de nuevos 1-fenoxi-2-hi- droxi-3-ter-butilamino propanos sustituidos.
JPS5170769A (en) 10*111 jihidoro 33 karubokishishipuroheputajin oyobi sono nn okisaido
IL45235A0 (en) Herbicidal compositions containing an alpha-amino acid derivative and one or more further active substituents
CA979362A (en) COMPOSITION FOR TREATMENT OF SHOCK CONTAINING .beta.-(2-PYRIDYL-LOWER ALKYL)-AMINE OR .beta.-(4-PYRIDYL-LOWER ALKYL)-AMINE AND NON-TOXIC ACID ADDITION SALTS THEREOF
JPS5270020A (en) Fungicidal composition for agriculture and gardening use
AU239740B2 (en) Antiseptic therapeutic compositions comprising 2, 4-dichlorobenzylalcohol
GB853519A (en) Inhibition of isoniazid acetylation
AU5231059A (en) Antiseptic therapeutic compositions comprising 2, 4-dichlorobenzylalcohol
CA610403A (en) Compositions for the influencing of plant growth
ES453237A1 (es) Un procedimiento para la produccion de una preparacion anti-hipertensiva.
CA590900A (en) Therapeutic compositions comprising 5-amino hexahydropyrimidines or salts thereof
AU252896B2 (en) Therapeutic composition containing 4-hydroxybutyric acid or salts thereof
CA654403A (en) Compositions containing 2-amino-5-lower alkyl-thiazole or therapeutically acceptable non-toxic acid addition salts of the thiazole derivative
AU239071B2 (en) Improvements in or relating to the surface treatment of titanium or titanium base alloy
CA606356A (en) Therapeutic compositions for the treatment of the scalp
ES403737A1 (es) Procedimiento para la obtencion de un medio herbicida.
AU262608B2 (en) Therapeutic composition comprising 3, - diethyl - 5 - methyl - 2,4 - piperidinedione and 7 - chloro - 2- methylamino - 5- phenyl - 3h - 1,4 - benzodiazepine - 4- oxide or its acid salt